Vabysmo (faricimab), guide for patients/caregivers. Information on important identified risks: infectious endophthalmitis, intraocular inflammation

18.03.2026 466 views

Вабісмо (фарицимаб), керівництво для пацієнтів/опікунів. Інформація щодо важливих ідентифікованих ризиків: інфекційний ендофтальміт, внутрішньочне запаленняPDF · 6.2 МБ

Завантажити

Vabysmo (faricimab), guide for patients/caregivers. Information on important identified risks: infectious endophthalmitis, intraocular inflammation

Forum "PHARMEXPERT 2026: pharmaceutical market in the new regulatory reality"

Forum "Clinical and preclinical studies in wartime: organization and development prospects"

Pharmaceutical forum "PHARMEXPERT 2025. eCTD and pricing in Ukraine – a strategic path to integration into the international regulatory space"

PHARMEXPERT 2024. Standards. Innovations. European integration

Vabysmo (faricimab), guide for patients/caregivers. Information on important identified risks: infectious endophthalmitis, intraocular inflammation

Other materials in this section

Forum "PHARMEXPERT 2026: pharmaceutical market in the new regulatory reality"

Forum "Clinical and preclinical studies in wartime: organization and development prospects"

Pharmaceutical forum "PHARMEXPERT 2025. eCTD and pricing in Ukraine – a strategic path to integration into the international regulatory space"

PHARMEXPERT 2024. Standards. Innovations. European integration